| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |